Challenges and Opportunities Facing Needle-Free Injection Technology

DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8b3f2c/needlefree_inject) has announced the addition of the "Needle-free Injection - Challenges and Opportunities" report to their offering.

While the technology continues to garner interest from drug developers and healthcare decision makers, the companies making and marketing needle-free injectors are evolving as they search for a strategy that will achieve commercial success. To increase the commercial prospects for NFIs, companies have invested in new device models that incorporate design enhancements and improved human engineering. The new generation of devices are lighter, have a sleek profile and employ warm colors, increasing their acceptance with end-users. The business approach of needle-free injection companies is also evolving. The historical model of the NFI developer as a device company licensing its technology to pharmaceutical firms is being challenged by newer companies that own NFI technology and use it to develop combination drug-device products in-house. Beyond mainstream injectable drug delivery are several niche markets such as animal health that are being pursued by specialty NFI device companies. Another group of companies continues to work with NGOs such as the World Health Organization (WHO) on improved devices for mass immunization in underdeveloped countries.

Key Topics Covered:
- Executive Summary
- Parenteral Delivery Market Overview
- Drug Injection Devices
- Traditional Needle/Syringes
- Safety Syringes
- Needle-free Injectors
- Pen Injectors
- Other Important Technologies
- Market Dynamics
- Competitive Landscape
- Needle-free Design & Technology
- Application
- End User/Practitioner Fill Injectors
- Prefilled Disposable Models
- Refillable Cartridge Designs
- Energy Source
- Specialized Designs
- Needle-free Injection Market Drivers
- Safety
- Regulation
- Patient/Consumer Sentiment
- Enhanced Compliance
- Near-term Needle-free Injection Applications
- Antivirals
- CNS
- Gene/DNA Delivery
- Human Growth Hormone
- Other Hormones
- Metabolic Diseases
- Pain Management
- Vaccines
- Emerging Markets
- Needle-free Injector Markets
- Healthcare/Practitioner
- Self-Administration
- Mass Immunization
- Needle-free Injector Platforms
- Self-Administration
- Practitioner/Healthcare
- Specialty Needle-free Injectors
- Market Factors
- Government Regulations
- Health Standards Organizations
- Rx-to-OTC Switching
- Alliances & Collaborations
- Private Labeling
- Company Profiles

This report is available as an electronic format. A site license for a single physical location and a global license are also available.

For more information visit http://www.researchandmarkets.com/research/8b3f2c/needlefree_inject

Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
press@researchandmarkets.com